Paper4076321
Pharmacokinetics of penbutolol and its metabolites in renal insufficiency.
Bernard N and 4 others. Eur J Clin Pharmacol, 1985. Cited by 9 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Pharmacokinetics of penbutolol and its metabolites in renal insufficiency. Papers, record 4076321. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4076321
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Kidney Diseases | Major topic |
| Penbutolol | Major topic |
| Propanolamines | Major topic |
| Adult | |
| Female | |
| Glucuronates | |
| Humans | |
| Hypertension | |
| Kinetics | |
| Male | |
| Middle Aged |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 436,357 | Single and divided doses of penbutolol. | Clin Pharmacol Ther | 1979 | https://conductscience.org/library/papers/436357 | PubMed |
| 2 | 7,015,536 | Penbutolol and furosemide in a fixed-dose combination-bio-equivalence of two formulations. | S Afr Med J | 1981 | https://conductscience.org/library/papers/7015536 | PubMed |
| 3 | 14,976 | Plasma level studies of penbutolol after oral dose in man. | J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/14976 | PubMed |
| 4 | 16,632 | Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man. | Br J Clin Pharmacol | 1977 | https://conductscience.org/library/papers/16632 | PubMed |
| 5 | 582,753 | Physico-chemical and anlytical studies of penbutolol. | Arzneimittelforschung | 1979 | https://conductscience.org/library/papers/582753 | PubMed |
| 6 | 7,076,761 | Determination of penbutolol and its hydroxylated metabolite in biological fluids by reversed-phase high-performance liquid chromatography. | J Chromatogr | 1982 | https://conductscience.org/library/papers/7076761 | PubMed |
| 7 | 7,047,173 | Penbutolol (Hoe 893d) in primary hypertension. Blood pressure effects, tolerance and plasma concentrations. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7047173 | PubMed |
| 8 | 489,760 | Plasma level profiles and clinical response of penbutolol after three different single oral doses in man. | J Clin Pharmacol | 1979 | https://conductscience.org/library/papers/489760 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36,930,375 | Occurrence, consumption level, fate and ecotoxicology risk of beta-agonist pharmaceuticals in a wastewater treatment plant in Eastern China. | Environ Monit Assess | 2023 | https://conductscience.org/library/papers/36930375 | PubMed |
| 34,112,223 | Extracorporeal treatment for poisoning to beta-adrenergic antagonists: systematic review and recommendations from the EXTRIP workgroup. | Crit Care | 2021 | https://conductscience.org/library/papers/34112223 | PubMed |
| 2,906,875 | Penbutolol: pharmacokinetics, effect on exercise tachycardia, and in vitro inhibition of radioligand binding. | Eur J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/2906875 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4076321
GET https://conductscience.org/api/papers/v1/4076321/authors